Publications en collaboration avec des chercheurs de Universidad de León (38)

2024

  1. Idiosyncratic Drug-Induced Liver Injury and Amoxicillin–Clavulanate: Spotlight on Gut Microbiota, Fecal Metabolome and Bile Acid Profile in Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

2023

  1. Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression

    Hepatology, Vol. 77, Núm. 5, pp. 1654-1669

2021

  1. Aging, gut microbiota and metabolic diseases: Management through physical exercise and nutritional interventions

    Nutrients, Vol. 13, Núm. 1, pp. 1-21

  2. Long-term effects of bariatric surgery on gut microbiota composition and faecal metabolome related to obesity remission

    Nutrients, Vol. 13, Núm. 8

  3. The synbiotic combination of akkermansia muciniphila and quercetin ameliorates early obesity and NAFLD through gut microbiota reshaping and bile acid metabolism modulation

    Antioxidants, Vol. 10, Núm. 12

2019

  1. A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non-Alcoholic Fatty Liver Disease

    Molecular Nutrition and Food Research, Vol. 63, Núm. 20

  2. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease

    DMM Disease Models and Mechanisms, Vol. 12, Núm. 5

  3. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice

    Molecular Nutrition and Food Research, Vol. 63, Núm. 8

  4. Study of Master Formulas for Animal Use in a Pharmacy

    Journal of Veterinary and Animal Research, Vol. 2, Núm. 1

2018

  1. Anti-inflammatory, immunomodulatory, and prebiotic properties of dietary flavonoids

    Polyphenols: Prevention and Treatment of Human Disease (Elsevier), pp. 327-345

  2. Autophagy as a molecular target of flavonoids underlying their protective effects in human disease

    Current Medicinal Chemistry, Vol. 25, Núm. 7, pp. 814-838

  3. Intestinal microbiota modulation in obesity-related non-alcoholic fatty liver disease

    Frontiers in Physiology, Vol. 9

2017

  1. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation

    Free Radical Biology and Medicine, Vol. 102, pp. 188-202

2015

  1. Fisiología del envejecimiento

    Universidad de León

  2. Flavonoids and related compounds in non-alcoholic fatty liver disease therapy

    Current Medicinal Chemistry, Vol. 22, Núm. 25, pp. 2991-3012

  3. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease

    Molecular Nutrition and Food Research, Vol. 59, Núm. 5, pp. 879-893

  4. Repression of the nuclear receptor small heterodimer partner by steatotic drugs and in advanced nonalcoholic fatty liver disease

    Molecular Pharmacology, Vol. 87, Núm. 4, pp. 582-594

2014

  1. Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin

    Laboratory Investigation, Vol. 94, Núm. 3, pp. 262-274

2013

  1. Anti-Inflammatory and Immunomodulatory Properties of Dietary Flavonoids

    Polyphenols in Human Health and Disease (Elsevier Inc.), pp. 435-452

  2. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; And repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1831, Núm. 4, pp. 803-818